Dihydroergotamine Mesylate

   
Google
 
Web NewDrugInformation.com

Dihydroergotamine Mesylate


Drug - Dihydroergotamine Mesylate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dihydroergotamine Mesylate
Multiple ingredients are in alphabetical order.

Strength - 1MG/ML
The potency of the active ingredient(s), Dihydroergotamine Mesylate. May repeat for multiple part products.

Applicant - PADDOCK
The firm name holding legal responsibility for Dihydroergotamine Mesylate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040475
The FDA assigned number to Dihydroergotamine Mesylate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Dihydroergotamine Mesylate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 28, 2003
The date Dihydroergotamine Mesylate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Dihydroergotamine Mesylate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Dihydroergotamine Mesylate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Paddock Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Dihydroergotamine Mesylate.

Dihydroergotamine Mesylate